Evidence map›Paper›PMID 39633146›Full record

ArticleCommunications biology2024

Transformers significantly improve splice site prediction.

Benedikt A Jónsson, Gísli H Halldórsson, Steinþór Árdal, Sölvi Rögnvaldsson, Eyþór Einarsson, Patrick Sulem, Daníel F Guðbjartsson, Páll Melsted, Kári Stefánsson, Magnús Ö Úlfarsson

Erratum issuedAbstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Benedikt A JónssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.ORCID 0000-0002-5401-5940
Gísli H HalldórssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.ORCID 0000-0001-7067-9862
Steinþór ÁrdaldeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Sölvi RögnvaldssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Eyþór EinarssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.ORCID 0009-0008-5814-6981
Patrick SulemdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.ORCID 0000-0001-7123-6123
Daníel F GuðbjartssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.ORCID 0000-0002-5222-9857
Páll MelsteddeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Kári StefánssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID 0000-0003-1676-864X
Magnús Ö ÚlfarssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland. mou@hi.is.ORCID 0000-0002-0461-040X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations that affect RNA splicing significantly impact human diversity and disease. Here we present a method using transformers, a type of machine learning model, to detect splicing from raw 45,000-nucleotide sequences. We generate embeddings with residual neural networks and apply hard attention to select splice site candidates, enabling efficient training on long sequences. Our method surpasses the leading tool, SpliceAI, in detecting splice sites in GENCODE and ENSEMBL annotations. Using extensive RNA sequencing data from an Icelandic cohort of 17,848 individuals and the Genotype-Tissue Expression (GTEx) project, our method demonstrates superior performance in detecting splice junctions compared to SpliceAI-10k (PR-AUC = 0.834 vs. PR-AUC = 0.820) and is more effective at identifying disease-related splice variants in ClinVar (PR-AUC = 0.997 vs. PR-AUC = 0.996). These advancements hold promise for improving genetic research and clinical diagnostics, potentially leading to better understanding and treatment of splicing-related diseases.

Indexed as

Machine LearningRNA Splice SitesComputational BiologyHumansRNA SplicingRNA Splice Sites

Identifiers

PMID39633146
PMCPMC11618611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.